 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | Indus Hospital |
| Street 1: | Korangi Crossing |
| Street 2: | Korangi |
| City: | Karachi |
| Province: | Sindh |
| Post Code: | 75190 |
| Country: | Pakistan |
| Phone: | 92214327697 |
| Organization Email: | info@indushospital.org.pk |
| Web Site: | http://www.indushospital.org.pk |
| Other Online Presence: | |
|
|
||||||||||||||||||||||||||||
General Information | |
| Board Constituency: | Developing Country NGO |
| Is your organization legally registered in your country: | Yes |
| If yes, please enter your registration number: | |
| Organization Type - Primary: | Non-Governmental Organization |
| Organization Type - Secondary: | Other Non-Governmental Organization (NGO) |
| Organization Description: | |
| The Indus Hospital is a state of the art tertiary care center accessible to the public free of charge. A team of local and expatriate professionals provide specialized medical care with an emphasis on innovation and research. The tertiary care facilities at the Hospital are complemented by community outreach programs focused on prevention and early detection of disease, encouraging community involvement and ownership. This service is designed to prevent the most common causes of childhood and adult deaths in low-income communities, primarily through vaccination and other low-cost strategies. High priority diseases include pneumonia, diarrhea, tuberculosis and malaria. The program aims to provide DOTS-based treatment of regular tuberculosis to the 1.2 million large population surrounding the Hospital, while providing DOTS-Plus care for MDR-TB patients at the city level. |
|
| Do you know about the UNHLM declaration: | |
Specializations / Areas of Work | |
|
Advocacy Delivery of health services and care Funding, including innovative and optimized approach to funding TB Care Research and Development Technical Assistance |
Other Organization Information | |
| Total number of staff in your organization: | 100 + |
| Number of full-time staff who are directly involved with TB: | 11 - 25 |
| Number of part-time staff who are directly involved with TB: | 11 - 25 |
| Number of volunteers who are directly involved with TB: | 26 - 50 |
| How did you hear about the Stop TB Partnership: | Involvement in TB control provision |
| If you were informed or referred by another partner of the Stop TB Partnership please tell us who: | |
| Why do you wish join the Stop TB Partnership: | Involvement in Stop TB Working Groups |
| Are you a member of a Stop TB national partnership: | No |
| Are you in contact with your national TB programme: | Yes |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
| The Indus Hospital is a non-profit, tertiary care facility that provides high quality health care completely free of cost to all patients. Indus Hospital operates community-based disease control programs primarily targeting the Hospital’s immediate catchment population of 2.6 million persons (in eastern Karachi). Patient care at the Indus Hospital is funded through philanthropic donations. Indus Hospital’s community-based programs are primarily funded through international and national research and development grants, although philanthropic donations have also been received for disease control programs. IRD and Indus Hospital have approached TB control (for both susceptible and drug-resistant TB) as a global health delivery challenge that requires innovative local solutions. Starting in 2008, the TB program raised over USD 800,000 over 2 years from private donors, corporate social responsibility (CSR) donations and donations in kind (e.g. medicines, food baskets). A BSL 3 lab was designed, built and made operational between 2008-2009 at the Indus Hospital, and since 2009 the lab has undergone successful annual external quality assurance by the WHO Supra-National Reference Laboratory (SNRL) network for first-line and second-line drug susceptibility testing. A purpose-built TB Out-Patient Department (Ghori Clinic) based upon air-borne infection control design principles was inaugurated in 2010, providing us the capacity to double the number of TB patients being seen at Indus Hospital. Currently, there are more than 3000 DOTS patients and over 300 MDR-TB patients on treatment at any given time. Indus Hospital is a Sub-Recipient (SR) for Pakistan’s successful USD 153 million R9 Global Fund grant for scale-up of PMDT in the provinces of Sindh and Balochistan over 5 years starting in 2011. This award is recognition by the NTP and Global Fund of the Indus Hospital TB Control Program’s capabilities for rapid implementation and scale-up of TB Control activities. |
|
Geographical Reach | |
| Which country is your headquarters located in: | Pakistan |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
Bangladesh Democratic Republic of the Congo Indonesia Kenya Pakistan Tajikistan Uganda Zimbabwe |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
TB Care Delivery: Indus Hospital was a recipient of the TB REACH Wave 1 Year 1 and Year 2 grant. The intervention in this grant focused on a public private partnership model i.e. working with general practitioners and community screeners to improve case detection rates through conditional cash transfers and mobile phone based data collection. Drug-Resistant TB: The Indus Hospital is a sub-recipient of the Global Fund R9 grant to Pakistan and responsible for 10 sites across Sindh and Balochistan to provide comprehensive MDR-TB treatment. In phase 1 (2010-2012) we will be responsible for treatment of 522 patients New Diagnostics: Indus Hospital was the first institution in Pakistan to receive the Gene Xpert machine funded through the TB REACH Wave 1 initiative. |
|
Declaration | |
| Declaration of interests: No conflicts of interest were delacred. | |
| Application date: | |
| Last updated: | September 19, 2013 |